DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
暂无分享,去创建一个
P. Parren | S. Verploegen | A. Labrijn | J. Neijssen | T. Salcedo | J. Schuurman | Joyce I. Meesters | S. Oostindie | G. Horbach | E. Breij | P. Engelberts | Irati Beltrán Hernández | E. N. van den Brink | I. Hiemstra | D. Schuurhuis | E. V. D. Brink | B. de Jong | B. D. Jong | Irati Beltran Hernandez